FindTrial
Sign In

Perioperative administration of nesiritide to improve the clinical prognosis of patients undergoing cardiovascular surgeries

Perioperative administration of nesiritide to improve the clinical prognosis of patients undergoing cardiovascular surgeries

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200060581
Enrollment
Unknown
Registered
2022-06-05
Start date
2022-07-01
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular diseases

Interventions

Nesiritide group:Nesiritide
Control group:Saline

Sponsors

Provincial Hospital affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1. Cardiovascular surgery patients; 2. NT-probNP > 900ng/ mL.

Exclusion criteria

Exclusion criteria: 1. Patient refused to participate in the study; 2. Patient was allergic to nesiritide.

Design outcomes

Primary

MeasureTime frame
NT-proBNP;—

Secondary

MeasureTime frame
TNT;Low cardiac syndrome incidence;Renal function;—

Countries

China

Contacts

Public ContactTan Qi

Provincial Hospital affiliated to Shandong First Medical University

deepblue1229@163.com+86 18753157303

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026